Related Experiment Video
Updated: Jul 26, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
The Association of Hypertension with Increased Mortality Rate During the COVID-19 Pandemic: An Update with
Ahmad R Al-Qudimat1,2, Ayisha Ameen3, Doaa M Sabir3
1Surgical Research Section, Department of Surgery, Hamad Medical Corporation, Doha, Qatar. aalqudimat@hamad.qa.
Insights
Hypertension is linked to increased COVID-19 mortality, but other factors like comorbidities and age also significantly raise death risks. This review highlights the complex interplay of risk factors in COVID-19 outcomes.
Area of Science:
- Public Health
- Epidemiology
- Internal Medicine
Background:
- The COVID-19 pandemic has seen numerous studies on risk factors for mortality.
- Hypertension (HTN) is a common comorbidity, and its association with COVID-19 mortality requires comprehensive updates.
Approach:
- A systematic review and meta-analysis were conducted following PRISMA guidelines.
- Searches were performed on PubMed, Scopus, and Cochrane databases for studies published between December 2019 and August 2022.
- 23 observational studies with over 611,000 patients were included.
Key Points:
- The overall mortality prevalence in the included studies was 0.5% (3119 deaths out of 611,522 patients).
- Pooled mortality rates varied significantly across studies.
- Subgroup analyses indicated that male patients with hypertension had a slightly lower mortality risk compared to female patients, particularly when men constituted over 50% of the cohort.
Conclusions:
- Hypertension is a significant risk factor for COVID-19 mortality.
- However, it is not the sole determinant; other comorbidities and advanced age substantially increase mortality risk.
- Further research into the multifactorial nature of COVID-19 mortality is warranted.
Background And Aim:
The impact of multiple risk factors on COVID-19 mortality has been previously reported in multiple systematic reviews and meta-analyses. The aim of this review is to provide a comprehensive update on the association between hypertension (HTN) and mortality in patients with COVID-19.
Methods:
A systematic review and meta-analysis were performed and followed the Preferred Reporting Items for Systematic Reviews (PRISMA) guidelines. A search was achieved using PubMed, Scopus, and Cochrane Databases for research publications on hypertension, COVID-19, and mortality published between December 2019 and August 2022.
Results:
A total of 23 observational studies involving 611,522 patients from 5 countries (China, Korea, the UK, Australia, and the USA) were included in our study. The confirmed number of COVID-19 with HTN cases in each study ranged from 5 to 9964. The mortality ranged from 0.17% to 31% in different studies. Pooled results show that the mortality rate of COVID-19 among the included studies ranges from a minimum of 0.39 (95% CI 0.13-1.12) to a maximum of 5.74 (95% CI 3.77-8.74). Out of the 611,522 patients, 3119 died which resulted in an overall mortality prevalence of 0.5%. Subgroup analyses indicated that patients with COVID-19 who have hypertension and male patients had slightly less risk of mortality than female patients [the percentage of men > 50%; OR 1.33: 95% CI (1.01, 1.76); the percentage of men ≤ 50%: OR 2.26; and 95% CI (1.15, 4.48)]. Meta-regression analysis results also showed a statistically significant association between hypertension and COVID-19 mortality.
Conclusion:
This systematic review and meta-analysis suggest that hypertension may not be the only risk factor associated with the increased mortality rate during the COVID-19 pandemic. In addition, a combination of other comorbidities and old age appears to increase the risk of mortality from COVID-19. The impact of hypertension on mortality rate among COVID-19 patients.
More Related Videos
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
05:15Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Related Concept Videos
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management